FINWIRES · TerminalLIVE
FINWIRES

午盤漲幅最大的股票

By

-- KalVista Pharmaceuticals (KALV) 和 Chiesi Group 週三宣布，雙方已達成最終協議，Chiesi 將以每股 27 美元的現金收購 KalVista，總交易額約為 19 億美元。雙方表示，該交易預計將於第三季完成。 受此消息提振，KalVista 股價飆漲 39%，盤中成交量從日均約 98.4 萬股增至超過 4,820 萬股。 Silicon Motion Technology (SIMO) 週二晚間公佈的第一季非 GAAP 盈利和銷售額均同比增長，超出市場預期。 受此消息提振，Silicon Motion Technology (SIMO) 股價飆漲 31%，盤中成交量從日均約 62.3 萬股躍升至超過 266 萬股。 Bloom Energy (BE) 週二晚間公佈的第一季調整後每股收益為 0.44 美元，高於去年同期的 0.03 美元。 FactSet 調查的分析師此前預期為 0.12 美元。該公司營收也輕鬆超越分析師預期。 受此消息提振，該公司股價飆漲22%，盤中交易量從日均約1,080萬股飆升至超過1,380萬股。

Price: $26.71, Change: $+7.47, Percent Change: +38.80%

Related Articles

Commodities

US Biofuels Update: Soybean Oil Futures Reach All-Time Highs, Pushing Soybeans Higher

Biofuels feedstock futures closed higher on Wednesday, with soybean oil reaching contract highs, while soybean prices followed.The Chicago Board of Trade July soybean futures contract closed 0.65% higher on Wednesday at $11.97 per bushel, while the CBOT July soybean oil futures contract settled 2.21% higher at 74.12 cents per pound.On Tuesday, the June ethanol futures contract on the Nymex ended 0.87% lower at $1.99 per gallon.US President Donald Trump reportedly plans to keep the US blockade in place, and as a result, crude futures jumped on Wednesday for the seventh time in the past eight sessions.Rhett Montgomery, DTN analyst, said that fresh fundamental news was slim on Wednesday."Soybeans are likely getting a boost from another contract high in soybean oil futures. Crush premiums continue to expand and are closing in on all-time highs set in October of 2022," Montgomery said.The analyst said market participants are closely watching Trump's upcoming visit to China in May. "With President Trump still on track to visit China in mid-May, it would appear the market's anxiety over the prolonged conflict with Iran has subsided at least temporarily," Montgomery said in a daily note.

Research

Research Alert: CFRA Maintains Hold Opinion On Shares Of Kimberly-clark Corp

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target by $6 to $104, 14x our 2026 EPS estimate (from 16x), a discount to its 19x five-year average forward multiple, reflecting integration risks stemming from the acquisition of Kenvue Inc. (KVUE 17 ***). We lower our 2026 EPS estimate to $7.45 from $7.56 and keep 2027's at $6.31. Following Q1 results, we maintain our Hold rating, reflecting a balanced assessment of operational momentum, with adjusted EPS of $1.97 beating the $1.95 consensus estimate, against a conservative full-year outlook. Management maintained organic sales growth guidance despite the Q1 beat, disappointing investors that expected an upward revision. Operating margin contracted 60 bps as higher operational and raw material costs offset productivity gains. Additionally, the KVUE acquisition introduces integration risks, having received shareholder approval but still pending regulatory approval. At current levels, we see balanced risk/reward and would become more constructive if management raised guidance.

$KMB
Insider Trading

Kopin Insider Sold Shares Worth $461,597, According to a Recent SEC Filing

Paul Christopher Baker, Chief Operating Officer, on April 28, 2026, sold 116,860 shares in Kopin (KOPN) for $461,597. Following the Form 4 filing with the SEC, Baker has control over a total of 480,005 common shares of the company, with 480,005 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/771266/000149315226019551/xslF345X05/ownership.xmlPrice: $3.98, Change: $-0.02, Percent Change: -0.62%

$KOPN